The Role of Nutraceuticals in Immune Function
A special issue of Nutrients (ISSN 2072-6643). This special issue belongs to the section "Nutritional Immunology".
Deadline for manuscript submissions: closed (31 December 2022) | Viewed by 23102
Special Issue Editors
Interests: food; nutrients; immunology; innate and adaptative response; immunometabolism; signaling pathways; flow cytometry; cell culture; allergy; allergic rhinitis; chronic rhinosinusitis
Special Issues, Collections and Topics in MDPI journals
Interests: biochemistry and molecular biology; immunology; fatty acids; postprandial state; chylomicron; olive oil; dendritic cells; myeloid lineage; triglyceride-rich lipoprotein; fatty liver; steatohepatitis; obesity; metabolic syndrome; leptin; inflammation; leptin resistance; Alzheimer’s disease
Special Issue Information
Dear Colleagues,
Nutraceuticals with therapeutic properties in immunity function are being studied as antioxidant, anti-inflammatory, anti-aging, anticancer and metabolic modulators.
There is evidence that phytochemicals such as sulforaphane, curcumin, naringenin or polyphenols can be used complementary to anti-inflammatory drugs, leading to the reduction in the dose level of such drugs and being able to even enhance their effects. Moreover, these bioactive molecules can help to prevent the development of diabetes mellitus, obesity, cancer, neurodegeneration, gastroenterological disorders and infections in the initial stages.
In response to pro-inflammatory stimuli, professional antigen-presenting cells (APCs) recognize pathogen or damage-associated molecular patterns, processing and presenting them on the surfaces of cells and modifying their phenotypic, metabolic and functional characteristics. Thus, APCs release mediators such as cytokines, chemokines and vasoactive amines, which act on the small blood vessels, promoting leukocyte migration to damaged tissues. Moreover, in this microenvironment, other endogenous factors are related to the induction of this stage of inflammation, such as advanced glycation end products, and oxidized lipoproteins can stimulate several pathways that, in turn, activate the transcription of pro-inflammatory genes.
Immunometabolism studies are emerging, with the goal of uncovering promising therapeutic potential in diseases involving inflammatory components. Immune cells are generally mediated by a shift to glycolytic metabolism, while anti-inflammatory and immune memory responses are generally supported by oxidative metabolism.
The aim of this Special Issue is to showcase new approaches associated with the therapeutic potential of nutraceuticals and immune function in treating inflammatory and autoimmune diseases. This Special Issue is open to preclinical and human studies.
Prof. Dr. Soledad Lopez-Enriquez
Prof. Dr. Gonzalo Alba Jiménez
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Nutrients is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- bioactive compounds
- immunoprotection
- immunometabolism
- preclinical and human studies
- monocytes/macrophages, dendritic cells, neutrophils, natural killer T cells, regulatory T cells
- ROS and autophagy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.